Company Coegin Pharma AB

Equities

COEGIN

SE0020357754

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-06-26 pm EDT 5-day change 1st Jan Change
7 SEK +2.34% Intraday chart for Coegin Pharma AB +3.55% +29.99%

Business Summary

Coegin Pharma AB, formerly GoldBlue AB (publ) is a Sweden-based biotechnology company. The Company focuses on the development of small molecule therapies aimed at the key enzyme, which is known for its involvement in a variety of inflammatory diseases as well as in cancer. Coegin Pharma AB provides consulting and management services in drug development as well.

Number of employees: 2

Managers

Managers TitleAgeSince
Director of Finance/CFO 49 22-03-31
Chief Tech/Sci/R&D Officer 66 04-12-31
Sales & Marketing 47 22-04-30
Corporate Officer/Principal 54 21-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 20-08-31
Director/Board Member 66 21-12-31
Director/Board Member 62 23-04-30
Chairman 49 23-04-30
62 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,961,467 5,591,322 ( 35.03 %) 0 35.03 %

Company contact information

Coegin Pharma AB

Mediacon Village

223 81, Lund

+

http://www.coeginpharma.com
address Coegin Pharma AB(COEGIN)
  1. Stock Market
  2. Equities
  3. COEGIN Stock
  4. Company Coegin Pharma AB